Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Histone modification is key in treating chronic inflammatory skin diseases.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.